Unity Biotechnology, Inc. (LON:0YC0)
1.955
-0.145 (-6.91%)
At close: Feb 21, 2025
Unity Biotechnology Statistics
Total Valuation
LON:0YC0 has a market cap or net worth of GBP 25.86 million. The enterprise value is 22.21 million.
Market Cap | 25.86M |
Enterprise Value | 22.21M |
Important Dates
The next estimated earnings date is Thursday, March 13, 2025.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +15.08% |
Shares Change (QoQ) | +0.20% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 14.85M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 2.45 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.36 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.45, with a Debt / Equity ratio of 1.73.
Current Ratio | 3.45 |
Quick Ratio | 3.31 |
Debt / Equity | 1.73 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -28,260.79 |
Financial Efficiency
Return on equity (ROE) is -86.95% and return on invested capital (ROIC) is -34.44%.
Return on Equity (ROE) | -86.95% |
Return on Assets (ROA) | -30.34% |
Return on Invested Capital (ROIC) | -34.44% |
Return on Capital Employed (ROCE) | -73.69% |
Revenue Per Employee | n/a |
Profits Per Employee | -859,586 |
Employee Count | 19 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.25% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +6.25% |
50-Day Moving Average | 1.65 |
200-Day Moving Average | 1.60 |
Relative Strength Index (RSI) | 49.66 |
Average Volume (20 Days) | 3,747 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.89 |
Income Statement
Revenue | n/a |
Gross Profit | -13.72M |
Operating Income | -21.08M |
Pretax Income | -16.33M |
Net Income | -16.33M |
EBITDA | -20.41M |
EBIT | -21.08M |
Earnings Per Share (EPS) | -0.99 |
Balance Sheet
The company has 21.66 million in cash and 18.23 million in debt, giving a net cash position of 3.44 million.
Cash & Cash Equivalents | 21.66M |
Total Debt | 18.23M |
Net Cash | 3.44M |
Net Cash Per Share | n/a |
Equity (Book Value) | 10.55M |
Book Value Per Share | 0.63 |
Working Capital | 16.03M |
Cash Flow
Operating Cash Flow | -16.81M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
LON:0YC0 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.08% |
Shareholder Yield | -15.08% |
Earnings Yield | -63.16% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1.
Last Split Date | Oct 20, 2022 |
Split Type | Reverse |
Split Ratio | 0.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |